Analysis of data from women diagnosed with stage I to IIIA BC at Kaiser Permanente Northern California and Washington databases reported an increasing trend in NACT use across BC subtypes, overall, and specifically among those with HER2-positive tumors 19 .
← all excerpts
Racial and ethnic disparities in neoadjuvant chemotherapy patterns and outcomes in early-stage HER2-positive breast cancer.
1
—
—